Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | +1.55% | -3.68% | -16.03% |
05-28 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
05-28 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.03% | 177M | |
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Roth Capital Initiates Compass Therapeutics at Buy Rating With $15 Price Target